Literature DB >> 2982442

Regulatory factors specific for adult and embryonic globin genes may govern their expression in erythroleukemia cells.

N P Anagnou, T Y Yuan, E Lim, J Helder, S Wieder, D Glaister, B Marks, A Wang, D Colbert, A Deisseroth.   

Abstract

In order to test if trans-acting regulatory factors specific for globin genes of the adult and embryonic stages of development exist in erythroid cells, transcriptionally active embryonic and adult globin genes on the same chromosome were transferred by cell fusion from the human leukemia cell K562 into phenotypically adult mouse erythroleukemia cells. Restriction-fragment-length polymorphisms of the K562 zeta (embryonic) globin genes were used to establish that all three copies of human chromosome 16 present in the K562 cell showed the same pattern of human globin gene expression after transfer to the mouse erythroleukemia cell. Adult (alpha) but not embryonic (zeta) human globin mRNA was detected in all nine of the independently derived mouse erythroleukemia hybrid cells, each of which contained human chromosome 16. Restriction endonuclease studies of the K562 alpha- and zeta-globin genes after transfer into the mouse erythroleukemia cell showed no evidence of rearrangements or deletions that could explain this loss of zeta-globin gene expression. These data suggest that regulation of globin gene expression in these erythroleukemia cells involves trans-acting regulatory factors specific for the adult and embryonic stages of development.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982442

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Cell type-specific protein-DNA interactions in the human zeta-globin upstream promoter region: displacement of Sp1 by the erythroid cell-specific factor NF-E1.

Authors:  C Y Yu; J Chen; L I Lin; M Tam; C K Shen
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

2.  v-abl activates embryonic globin gene expression in mouse erythroleukemia cells.

Authors:  A R Lopez; J Barker; A B Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Chronic myelogenous leukemia--recent advances in treatment and pathogenesis.

Authors:  A B Deisseroth; S Purohit; A R Lopez
Journal:  West J Med       Date:  1986-03

4.  Chromatin structure and developmental expression of the human alpha-globin cluster.

Authors:  M Yagi; R Gelinas; J T Elder; M Peretz; T Papayannopoulou; G Stamatoyannopoulos; M Groudine
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

5.  Developmental programs of human erythroleukemia cells: globin gene expression and methylation.

Authors:  T Enver; J W Zhang; N P Anagnou; G Stamatoyannopoulos; T Papayannopoulou
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

6.  Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice.

Authors:  C S Trempus; S Ward; G Farris; D Malarkey; R S Faircloth; R E Cannon; J F Mahler
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

7.  Promoter sequences required for function of the human gamma globin gene in erythroid cells.

Authors:  N P Anagnou; S Karlsson; A D Moulton; G Keller; A W Nienhuis
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

8.  Comparative assessment of lymph node micrometastasis in cervical, endometrial and vulvar cancer: insights on the real time qRT-PCR approach versus immunohistochemistry, employing dual molecular markers.

Authors:  Kalliopi I Pappa; Alexandros Rodolakis; Ioanna Christodoulou; Maria Gazouli; Sofia Markaki; Aris Antsaklis; Nicholas P Anagnou
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.